Page 767 - Clinical Application of Mechanical Ventilation

Index 733

Restrictive lung disease, 585 SpO 2 , and airplane cabin pressure, 603t
Right arterial pressure waveform, 283 Spontaneous breathing, 28, 28t
Right ventricle, 33–34 Spontaneous breathing mode, 86–87
Ringer’s lactate solution, 402 Spontaneous breathing trial (SBT), 224, 527, 528t
Rise time percent, 341 failure, 527, 529t
Rocuronium, 434t, 437t Spontaneous frequency, 377–378, 521
RSI. See Rapid sequence intubation (RSI) Spontaneous tidal volume, 377–378, 521
Spontaneous ventilation
S during mechanical ventilation, 323–325
and pressure support, 340–343
Saline solution, 398 Sputum cultures, 399–400
Salmeterol xinafoate, 425t Square flow pattern, 227–228
SALT (Sort, Assess, Life-saving interventions, Treatment/ START (Simple Triage and Rapid Treatment), 591–592,
Transport), 592, 593f 592f
SaO 2 , 520 Static compliance, 6t, 7–10, 7t, 525, 691–692
Secretions Status asthmaticus case study, 620–625
collection of, 475 Stethoscope, 161, 248–249
removal of, 398 Strategic national stockpile (SNS), 594–595
Sedation, assessment of, 441–442, 442t Stridor, 184
Sedatives, 440–442 Stroke volume, 31, 279, 293
Seizures, medications for, 447–448 Stroke volume index, 293
Sellick’s maneuver, 170, 170f Stylet, 157, 161
Serum electrolytes, 402–405 Subglottic secretion drainage, 499
Servo, 56 Succinylcholine, 170, 436, 437t
Severe hypoxemia, 217–218 Suction catheter, 173
Shock, 20t, 502 Surfactant, 548
Shunt equation natural, 550
classic physiologic, 696–697 synthetic, 549–550
estimated, 697–698 types and dosages, 549–551, 551t
Shunt percent, 14, 15t Surfactant replacement therapy, 548–551
Sidestream analyzer, 261, 262f history, 548–549
Siemens 300A, 108 indications for, 549, 550t
Sigma receptor, 443 outcomes, 551
SIMV. See Synchronized intermittent mandatory ventilation types of surfactant and dosages, 549–551, 551t
(SIMV) Surfaxin, 549–550, 551t
Sine flow pattern, 228–229, 228f Survanta, 550, 551t
Sine wave, 72–73 SvO 2 , 294–295
Sinusoidal waveform, 72–75, 72f, 73f, 74f, 311, 312 Swan-Ganz catheter, 284, 285f
Sleep apnea, 196–197, 196t Sympathetic nervous system, 422, 423f, 424t
Sleep disorders, 19t Sympathomimetic bronchodilators, 423, 423–426
Smoke inhalation case study, 631–635 Synchronization window, 98
Sniffing position, 164, 164f Synchronized intermittent mandatory ventilation (SIMV),
Sodium, 37t, 402, 403t 97–100, 220, 323–324
abnormalities, 403–404, 403t, 434–435 advantages of, 99–100
normal, 701 characteristics of, 100t
SOFA (Sequential Organ Failure Assessment), 592–593, complications of, 100
594t defined, 97
Speaking valves, 176–178, 177f indications for, 99
contraindications for, 178 mandatory breath-triggering mechanism, 97–98
positive pressure ventilation, 178 and pressure support ventilation, 342–343
safety requirements, 178, 178t pressure tracing, 98f
Spinal cord injury, 19t spontaneous breath-triggering mechanism, 98–99
Splanchnic hypoperfusion, 40t and weaning, 529–530

Copyright 2013 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.